glp-1 drugs covered by insurance Insurer strategies to control costs associated with weight loss Members across the state did

Semaglutide , taken weekly: Possibly the most well-known of them all, FDA-approved under the brand names Ozempic for type 2 diabetes and to reduce the risk of a major adverse cardiovascular event in adults with type 2 diabetes or an established cardiovascular disease and Wegovy for obesity

Gastrointestinal modulation: The medication slows gastric emptying meaning food stays in the stomach longer leading to prolonged fullness and reduced meal frequency

Lifestyle changes made during treatment This is the single most important predictor of success after stopping GLP-1 medications

Hypertension is the most common preventable risk factor for CVDs (including coronary heart disease, heart failure, stroke, myocardial infarction, atrial fibrillation, and peripheral artery disease), chronic kidney disease, and cognitive impairment, and also the main single factor for deaths and disability worldwide (133)

In macrophages, GLP-1 signaling promotes polarization from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype through STAT6 activation and metabolic reprogramming [40,41,42]